Epidemiological Profiles of Respiratory Syncytial Virus Infection Among Hospitalized Children in a Tropical Setting: A Large Laboratory‐Based Surveillance Study From Hainan, China
Sep 2026· Journal of Medical Virology· Vol 98· 0 citations· 40 references
Medicine
TL;DR
The RSV burden was concentrated in infancy, with distinct subtype‐specific age patterns and pronounced rainy‐season seasonality, informing the timing and targeting of RSV preventive strategies.
Abstract
Respiratory syncytial virus (RSV) is a leading cause of acute respiratory infection in young children, yet subtype‐specific and age‐stratified epidemiological patterns remain incompletely characterised in tropical settings. To address this gap, we aimed to assess the age distribution and seasonal patterns of RSV infections in a large hospitalized paediatric population. We analysed surveillance data from 27,440 children tested for RSV. Age‐specific positivity and subtype distributions were estimated. Seasonal dynamics were assessed using generalised linear mixed models to estimate annual amplitude, peak timing, and epidemic duration. Multivariable logistic regression examined independent associations of age, sex, and season with RSV infection. Our results showed that RSV infection was highly concentrated in early life, and positive rates peaked at 27.7% (95% CI: 25.4–30.2) among infants aged 2–3 months and declined with age. The mean age at infection was 2.0 years (2.2 for RSV‐A; 1.7 for RSV‐B). RSV‐B predominated in early infancy, whereas RSV‐A became dominant from 1 year onward (p < 0.001). Transmission was strongly seasonal, with 76.8% of infections occurring during the rainy season. In conclusion, the RSV burden was concentrated in infancy, with distinct subtype‐specific age patterns and pronounced rainy‐season seasonality, informing the timing and targeting of RSV preventive strategies.
Respiratory syncytial virus (RSV) is the foremost viral cause of acute lower respiratory infections (ALRIs) in children under five years of age, yet surveillance data from rural India remain conspicuously scarce. This cross-sectional study simultaneously characterised RSV seroprevalence and active molecular infection i...
D. Hinge, S. Patil, Vinit Deshmukh· Indian Journal of Medical Mi...· 0 citations
Respiratory syncytial virus (RSV) is a leading cause of pediatric respiratory infections. This systematic review and meta-analysis aims to estimate the in-hospital positivity among children in Europe post-COVID-19 and prior to the implementation of the recent RSV prophylactic strategies. A systematic search was conduct...
M. Berikopoulou, Danai K. Giavasoglou, Argyro Konstantopoulou et al.· Journal of Clinical Virology· 0 citations
Background National population-based respiratory syncytial virus (RSV) direct burden-of-disease estimates on outpatient, emergency room (ER) and hospitalization settings are scarce among Mexican children. These estimates are key to inform the development of preventive public policies and to strengthen seasonal clinical...
R. Wong-Chew, Cristina Gutiérrez-Delgado, N. Hernández-Llanes et al.· Frontiers in Pediatrics· 0 citations
Mycoplasma pneumoniae (MP) is a major cause of pediatric respiratory infections, characterized by cyclical epidemics and age- and season-specific patterns. However, long-term epidemiological data spanning multiple epidemic cycles are limited. We conducted a 20-year retrospective study of children (< 18 years) hospitali...
Zhe M. D. Wang, Hui-Quan Sun, Q. Shen et al.· Egyptian Pediatric Associati...· 0 citations
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants and older adults worldwide. This retrospective study investigated the epidemiology and molecular characteristics of RSV in Taiwan from 2018 to 2024 using data from the National Community Virus Surveillance System, whic...
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections in young children. In 2019, RSV was estimated to cause approximately 33 million acute lower respiratory infections, 3.6 million hospitalisations and more than 101,000 deaths among children under five years of age, with more than...
N. Rave· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.